Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MultiMedRx vs Thriving Again

MultiMedRx
Graded #393

Lower grade

vs+1.8999999999999986
Thriving Again
Graded #341

Higher grade

The verdict

Thriving Again takes it — 59.5/100 to 57.6/100, but only just.

Thriving Again grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Thriving Again is a US telehealth platform positioned around premium men's health and optimization, with hormone/TRT, peptides, and a GLP-1 weight loss line. MultiMedRx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationMultiMedRx +13
53
40
Clinical oversightMultiMedRx +3
79
76
Labs & monitoringThriving Again +35
53
88
FulfillmentMultiMedRx +5
67
62
Contract termsThriving Again +6
49
55
MultiMedRx · left barThriving Again · right bar

The numbers

MetricMultiMedRxThriving Again
WeighScore57.6/10059.5/100
GradeCC
Scorecard rank#393#341
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
MultiMedRx

Graded #393 · C

Strengths

  • Legal entity disclosed (MMRX MultiMedRx LLC) — uncommon transparency
  • Two physical addresses listed: Newport Beach, CA and Reno, NV
  • LegitScript seal present
  • Features brand-name GLP-1s (Ozempic, Wegovy, Zepbound) — rare in a mostly compounded-only field
  • Broader cardiometabolic menu (metformin, testosterone, HRT) alongside GLP-1

Where it loses points

  • No Mounjaro or Foundayo in the brand-name lineup (only Ozempic, Wegovy, Zepbound)
  • Monthly GLP-1 pricing isn't published — gated behind the consultation
  • $100 consultation fee adds friction; many peers bundle it into the medication price
  • Per-state availability not listed; only CA and NV offices disclosed
  • Whether compounded GLP-1 is offered isn't clear — verify during intake
Thriving Again

Graded #341 · C

Strengths

  • Compounded GLP-1 with at-home labs and ongoing provider messaging
  • Advertises nationwide coverage with 500+ licensed providers
  • Pre-filled syringe delivery simplifies dosing
  • Combines weight loss with hormone and peptide optimization

Where it loses points

  • No specific GLP-1 dose or monthly pricing published online
  • Weight loss is one vertical alongside men's hormone and TRT care
  • Compounded products are not FDA-approved or evaluated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard